Anti-UBQLN2 antibody [6H9]
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(6 Publications)
Mouse Monoclonal UBQLN2 antibody. Suitable for WB, ICC/IF and reacts with Mouse, Human, Rat samples. Cited in 6 publications. Immunogen corresponding to Recombinant Fragment Protein within Human UBQLN2.
View Alternative Names
N4BP4, PLIC2, HRIHFB2157, UBQLN2, Ubiquilin-2, Chap1, DSK2 homolog, Protein linking IAP with cytoskeleton 2, Ubiquitin-like product Chap1/Dsk2, PLIC-2, hPLIC-2
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-UBQLN2 antibody [6H9] (AB190283)
Immunofluorescent analysis of HeLa cells labeling UBQLN2 with ab190283 at 1/1000 dilution. Vimentin is stained in red.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-UBQLN2 antibody [6H9] (AB190283)
NIH/3T3 (mouse embyro fibroblast cell line) cells stained for UBQLN2 (green) using ab190283 at 1/1000 dilution in ICC/IF. Costained with chicken pAb to lamin A/C at 1/5,000 dilution (red). The blue is DAPI staining of nuclear DNA.
- WB
Supplier Data
Western blot - Anti-UBQLN2 antibody [6H9] (AB190283)
All lanes:
Western blot - Anti-UBQLN2 antibody [6H9] (ab190283) at 1/1000 dilution
Lane 1:
NIH/3T3 (mouse embyro fibroblast cell line) cell lysate
Lane 2:
C6 (rat glial tumor cell line) cell lysate
Lane 3:
HEK-293 (human epithelial cell line from embryonic kidney) cell lysate
Lane 4:
HeLa (human epithelial cell line from cervix adenocarcinoma) cell lysate
Lane 5:
SH-SY5Y (human neuroblastoma cell line from bone marrow) cell lysate
Lane 6:
Rat whole brain lysate
Lane 7:
Mouse whole brain lysate
Predicted band size: 66 kDa
false
- WB
Supplier Data
Western blot - Anti-UBQLN2 antibody [6H9] (AB190283)
All lanes:
Western blot - Anti-UBQLN2 antibody [6H9] (ab190283) at 1/1000 dilution
Lane 1:
Primary mouse neuron and glia cell cultures
Lane 2:
Primary mouse neuron and glia cells transduced with Human ubiquilin 2 wild type
Lane 3:
Primary mouse neuron and glia cells transduced with ubiquilin 2 P506T mutant
Lane 4:
Primary mouse neuron and glia cells transduced with ubiquilin 2 P497S mutant
Lane 5:
Primary mouse neuron and glia cell cultures transduced with enhanced GFP control
Lane 6:
HeLa cell lysate
Lane 7:
3T3 cell lysate
Predicted band size: 66 kDa
false
- WB
Lab
Western blot - Anti-UBQLN2 antibody [6H9] (AB190283)
Western blot : Anti-UBQLN2 antibody [6H9] (ab190283) staining at 1/1000 dilution, shown in green; Rabbit Anti-GAPDH antibody [EPR16891] (ab181602) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab190283 was shown to bind specifically to UBQLN2. A band was observed at 73 kDa in wild-type A549 cell lysates with no signal observed at this size in UBQLN2 knockout cell line. To generate this image, wild-type and UBQLN2 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse IgG H&L 800CW and Goat anti-Rabbit IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-UBQLN2 antibody [6H9] (ab190283) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
UBQLN2 knockout A549 cell lysate at 20 µg
Lane 3:
HAP1 cell lysate at 20 µg
Lane 4:
HEK293 Nuclear cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Mouse IgG H&L 800CW and Goat anti-Rabbit IgG H&L 680RD at 1/20000 dilution
Observed band size: 73 kDa
false
- WB
Lab
Western blot - Anti-UBQLN2 antibody [6H9] (AB190283)
ab190283 was shown to react with UBQLN2 in wild-type HAP1 cells in Western blot with loss of signal observed in a UBQLN2 knockout cell line. Wild-type HAP1 and UBQLN2 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab190283 overnight at 4 °C at a 1/2000 dilution. Blots were incubated with secondary antibodies at 0.2ug/mL before imaging.
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-UBQLN2 antibody [6H9] (ab190283) at 1/2000 dilution
Lane 1:
Wild-type HAP1 lysate at 20 µg
Lane 2:
UBQLN2 knock-out HAP1 lysate at 20 µg
Observed band size: 66 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
UBQLN2 interacts with other proteins involved in protein quality control. It participates in complexes that manage protein homeostasis by assisting in the degradation of misfolded or damaged proteins. This action prevents the accumulation of toxic protein aggregates. UBQLN2's role in the cellular protein degradation pathway highlights its importance in maintaining cellular function and integrity.
Pathways
UBQLN2 engages in the endoplasmic reticulum-associated degradation (ERAD) pathway which ensures the elimination of misfolded proteins from the ER. It also links to the autophagy-lysosome pathway. UBQLN2 interacts with VCP/p97 in these pathways an important protein that assists in extracting ubiquitinated proteins for degradation. Through these interactions UBQLN2 contributes a pivotal role in maintaining cellular homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
F1000Research 12:355 PubMed37359784
2023
Applications
WB, ICC, IP
Species
Human, Human, Human
eLife 12: PubMed37039476
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:2306 PubMed35484142
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 2:100360 PubMed34467244
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer medicine 9:4083-4094 PubMed32293796
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 5:13416 PubMed26293199
2015
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com